World Alliance Forum in San Francisco
Our knowledge of human stem cells is quickly deepening and expanding today, as are the possibilities and visions of stem-cell applications, ranging from disease research and drug development to growing entirely new organs for transplant. While stem-cell technologies are creating a paradigm shift in the field of medicine and society at large, many challenges still remain before we are able to benefit from them. This year’s World Alliance Forum will bring together many leading figures in the academic, industry and regulatory arenas, including Dr. Shinya Yamanaka, the 2012 Nobel-Prize winning iPS-cell expert.
This year’s Forum will focus on the exciting possibilities of stem-cell technology as well as the challenges that need to be overcome for practical application. It is the forum’s goal to: (1) discuss the exciting possibilities of stem-cell applications and how they will affect our future; (2) examine the accompanying research, business and systemic hurdles; and (3) establish networks of experts for the development of stem cells and regenerative medicine as an industry. The profit raised in this forum will be used towards the industrialization of regenerative medicine and cultivation of human resources.
In the morning, the Forum will host ambitious startups and companies taking advantage of the waves of new academic discoveries in the field of stem cells and regenerative medicine. Businesses in other areas – such as bio-device manufacturing, insurance, law, and IT – will also be invited to discuss what regenerative medicine means to them. Finally, investors, incubators, and academics will join the conversation to explore ways to build a collaborative environment in the new stem cell and regenerative medicine industries.
The Forum will feature Dr. Yamanaka’s Keynote Speech and other speeches and panel discussions by top researchers such as Drs. Irving Weissman (Stanford University), Deepak Srivastava (Gladstone Institutes), Hiromitsu Nakauchi (University of Tokyo), and Hideyuki Okano (Keio University). In the main panel, they will be joined by another Nobel Prize recipient, Dr. Paul Berg (Stanford University). The topics in the afternoon will include how their research will be applied and what impact these applications will have on medicine and the society at large. The Forum will be concluded with a networking reception.
The Forum will be open to the public. Registration is now open, and the Early-Bird offer will expire on September 30, 2013. For more information and to register, please visit www.wafsf.org.
The 2013 World Alliance Forum in San Francisco is organized by the Alliance Forum Foundation; co-organized by Consulate General of Japan in San Francisco; sponsored by Rohto Pharmaceutical, DEFTA Partners, Medipost, TOMY Digital Biology, ReproCELL, Plasticell, and many more; and supported by Alliance for Regenerative Medicine (ARM), California Institute for Regenerative Medicine (CIRM), California Institute for Quantitative Biosciences (QB3), Gladstone Institutes, Hara Research Foundation, Alliance Forum Executive Club, Japan Bio Community (JBC), Japan Society of Northern California, Japanese Chamber of Commerce of Northern California (JCCNC), Japanese University Network of the Bay Area (JUNBA), Keizai Society, and US-Asia Technology Management Center at Stanford University.
Contact: Keiko Noguchi, Executive Director, 2013 World Alliance Forum in San Francisco (email@example.com)